Short‐ and long‐term follow‐up of thyroid dysfunction after allogeneic bone marrow transplantation without the use of preparative total body irradiation
Autor: | Eliane Gluckman, Selim Aractingi, Gérard Socié, Marie-Helene Schlageter, Helene Esperou, Marie-Elisabeth Toubert, Patrick Vexiau, Jean-Didier Rain, Agnès Devergie, Patricia Ribaud, Jean‐Paul Beressi, Nathalie Parquet |
---|---|
Rok vydání: | 1997 |
Předmět: |
Male
endocrine system medicine.medical_specialty endocrine system diseases Gastroenterology Internal medicine medicine Humans Transplantation Homologous Euthyroid Aplastic anemia Bone Marrow Transplantation Triiodothyronine business.industry Thyroid Hematology Total body irradiation medicine.disease Hematologic Diseases Thyroid Diseases Surgery medicine.anatomical_structure Female business Complication Whole-Body Irradiation hormones hormone substitutes and hormone antagonists Busulfan Follow-Up Studies Euthyroid sick syndrome medicine.drug |
Zdroj: | British Journal of Haematology. 98:453-457 |
ISSN: | 1365-2141 0007-1048 |
DOI: | 10.1046/j.1365-2141.1997.2433060.x |
Popis: | We studied the incidence and potential prognostic value of thyroid abnormalities after allogeneic bone marrow transplantation (BMT) without total body irradiation (TBI) conditioning. 77 consecutive patients who received a chemotherapy-alone-based conditioning regimen pretransplant were included. Free serum thyroxine (FT4), free serum triiodothyronine (FT3) and serum thyrotropin (TSH) levels were assayed before and 3 and 14 months after BMT. Patients were classified in three categories: normal thyroid profile if FT3 and FT4 were within the normal range and TSH was normal or low, peripheral thyroid insufficiency (PTI) if TSH was >4 mIU/l, or an ‘euthyroid sick syndrome’ (ETS) if FT3 and/or FT4 were low and TSH was normal or low. The incidence of thyroid dysfunction at 3 months was 57%, and 29% at 14 months. This was mostly due to the occurrence of ETS which was more frequent at 3 months (48%, 29/61) than at 14 months (19%, 9/48). Furthermore, at 3 months, survival was significantly lower in the ETS group (34.5%) than in the euthyroid group (96.2%), or in the PTI group (83.3%) (P |
Databáze: | OpenAIRE |
Externí odkaz: |